Company Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:38:09 2026-03-16 am EDT			5-day change	1st Jan Change
4.830 ^USD	+2.33%		-4.51%	-23.43%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Business description: Quanterix Corporation

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Number of employees: 450

Sales by Activity: Quanterix Corporation

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Diagnostic Kits / Equipment	111M	106M	122M	137M	139M

See all business segments

Geographical breakdown of sales: Quanterix Corporation

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
North America	65.3M	64.64M	75.28M	86.59M	85.11M
Europe, Middle East, and Africa (EMEA)	29.92M	27.71M	31.55M	34.92M	36.72M
Asia Pacific	10.12M	12.6M	14.3M	13.93M	16.82M

See all geographic segments

Executive Committee: Quanterix Corporation

Manager	Title	Age	Since
Everett Cunningham CEO	Chief Executive Officer	59	2026-01-18
Vandana Sriram DFI	Director of Finance/CFO	52	2023-08-20
Michael F. Miller COO	Chief Operating Officer	-	2024-05-20
Alexandra Phillips CTO	Chief Tech/Sci/R&D Officer	-	2021-12-31
Mark Roskey CTO	Chief Tech/Sci/R&D Officer	66	-

See QUANTERIX CORPORATION governance

Composition of the Board of Directors: Quanterix Corporation

Director	Title	Age	Since
Karen Flynn BRD	Director/Board Member	62	2022-06-05
William Donnelly CHM	Chairman	63	2025-03-23
Jeffrey Elliott BRD	Director/Board Member	48	2024-08-18
Ivana Magovcevic-Liebisch BRD	Director/Board Member	57	2024-10-01
Scott Mendel BRD	Director/Board Member	59	2025-07-07
Myla Lai-Goldman BRD	Director/Board Member	68	2025-07-07
Garret Hampton BRD	Director/Board Member	60	2025-11-19
Alan Sachs BRD	Director/Board Member	-	2025-11-19

Composition of the Board of Directors

Shareholders: Quanterix Corporation

Name	Equities	%	Valuation
Ameriprise Trust Co. 10.75 %	4,996,073	10.75 %	33 M $
Portolan Capital Management LLC 9.74 %	4,525,553	9.74 %	30 M $
BlackRock Advisors LLC 6.954 %	3,231,196	6.954 %	21 M $
Akoya Biosciences, Inc. 6.361 %	2,955,532	6.361 %	19 M $
Vanguard Fiduciary Trust Co. 5.763 %	2,677,833	5.763 %	18 M $

List of QUANTERIX CORPORATION shareholders

Company details: Quanterix Corporation

Quanterix Corp.

900 Middlesex Turnpike, Building 1

01821, Billerica

http://www.quanterix.com

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
QUANTERIX CORPORATION	+2.33%	-4.51%	-33.10%	-59.69%	222M
THERMO FISHER SCIENTIFIC, INC.	+1.90%	-7.35%	-9.06%	-15.19%	173B
INTUITIVE SURGICAL, INC.	+2.34%	-1.54%	-0.58%	+102.07%	168B
DANAHER CORPORATION	+1.04%	-4.58%	-10.78%	-23.92%	132B
BOSTON SCIENTIFIC CORPORATION	+0.87%	-2.67%	-29.24%	+44.89%	103B
SIEMENS HEALTHINEERS AG	-1.12%	-3.75%	-27.06%	-23.67%	49.5B
EDWARDS LIFESCIENCES CORPORATION	+2.32%	-0.07%	+19.22%	+2.80%	47.52B
RESMED, INC.	-0.22%	-7.97%	+3.58%	+10.18%	33.48B
GE HEALTHCARE TECHNOLOGIES INC.	+1.62%	-4.60%	-12.51%	-5.83%	32.25B
AGILENT TECHNOLOGIES, INC.	+1.01%	-3.14%	-7.76%	-17.42%	31.51B
Average	+1.22%	-4.55%	-10.73%	+1.42%	76.97B
Weighted average by Cap.	+1.39%	-4.56%	-9.16%	+18.81%